Toll-like receptor 4 is a therapeutic target for prevention and treatment of liver failure.
Engelmann C, Sheikh M, Sharma S, Kondo T, Loeffler-Wirth H, Zheng YB, Novelli S, Hall A, Kerbert AJC, Macnaughtan J, Mookerjee R, Habtesion A, Davies N, Ali T, Gupta S, Andreola F, Jalan R.
Engelmann C, et al.
J Hepatol. 2020 Jul;73(1):102-112. doi: 10.1016/j.jhep.2020.01.011. Epub 2020 Jan 24.
J Hepatol. 2020.
PMID: 31987990